Founded in 2002 and headquartered in Sparta, New Jersey, Acceptys focuses on creating anti-cancer and anti-viral human antibodies specifically designed for lung, pancreatic, gastric, and colon cancers. With a strong emphasis on research and development, the company aims to provide innovative solutions to combat these diseases. Acceptys operates as a subsidiary of Patrys Limited, and its mission is to advance the field of antibody therapies in the fight against cancer and infectious diseases.